84 unchanged sentences
F ourteenth Amendment to Lease dated January 14, 2022 between Omeros Corporation and BMR-201 Elliott Avenue LLC
+Added: Fifteenth Amendment to Lease dated November 1, 2022 between Omeros Corporation and BMR-201 Elliott Avenue LLC
+Added: Sixteenth Amendment to Lease dated July 8, 2024 between Omeros Corporation and BMR-201 Elliott Avenue LLC
+Added: Seventeenth Amendment to Lease dated December 18, 2024 between Omeros Corporation and BMR-201 Elliott Avenue LLC
License Agreement between Omeros Corporation and Daiichi Sankyo Co., Ltd.
5 unchanged sentences
Form of capped call transaction confirmation, in reference to the 5.25% Convertible Senior Notes due 2026
+Added: Combined Development and Commercial Supply Agreement, effective as of May 16, 2018, between Omeros Corporation and Vetter Pharma international GmbH
Master Services Agreement, dated July 28, 2019, between Omeros Corporation and Lonza Biologics Tuas Pte.
3 unchanged sentences
Amended and Restated Royalty Purchase Agreement between Omeros Corporation and DRI Healthcare Acquisitions LP dated February 1, 2024
+Added: Credit and Guaranty Agreement, dated as of June 3, 2024, among Omeros Corporation, certain subsidiaries of Omeros Corporation, as guarantors, various Lenders and Wilmington Savings Fund Society, FSB, as Administrative Agent and Collateral Agent
+Added: Pledge and Security Agreement, dated as of June 3, 2024, between Omeros Corporation, nura inc.
+Added: and Wilmington Savings Fund Society, FSB, as Collateral Agent
+Added: Omeros Corporation Insider Trading Policy
Consent of Independent Registered Public Accounting Firm
24 unchanged sentences
and Chairman of the Board of Directors
−Removed: April 1, 2024
+Added: March 31, 2025
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
2 unchanged sentences
President, Chief Executive Officer and Chairman of the Board of Directors (Principal Executive Officer)
−Removed: April 1, 2024
+Added: March 31, 2025
Demopulos, M.D.
−Removed: /s/ MICHAEL A.
Vice President, Finance, Chief Accounting Officer and Treasurer (Principal Financial Officer and Principal Accounting Officer)
−Removed: April 1, 2024
+Added: March 31, 2025
/s/ THOMAS F.
−Removed: April 1, 2024
+Added: March 31, 2025
/s/ THOMAS J.
−Removed: April 1, 2024
+Added: March 31, 2025
DEMOPULOS, M.D.
−Removed: April 1, 2024
+Added: March 31, 2025
Demopulos, M.D.
/s/ ARNOLD C.
−Removed: April 1, 2024
+Added: March 31, 2025
HOOD, M.D., PH.D.
−Removed: April 1, 2024
+Added: March 31, 2025
Hood, M.D., Ph.D.
/s/ DIANA PERKINSON, M.D.
−Removed: April 1, 2024
+Added: March 31, 2025
Diana Perkinson, M.D.
−Removed: April 1, 2024
+Added: /s/ RAJIV SHAH, M.D.
+Added: March 31, 2025
Rajiv Shah, M.D.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.